1983
DOI: 10.1161/01.hyp.5.6.908
|View full text |Cite
|
Sign up to set email alerts
|

Role of catecholamines and vasopressin in cardiovascular responses to bilateral dorsolateral transection of the medulla oblongata in the rat.

Abstract: SUMMARY The role of sympathetic and other pressor systems in the development of fulminant hypertension induced by baroreceptor deafferentation is still unclear. We studied the effects of acute hypertension produced by bilateral dorsomedullary knife cuts lateral to the nucleus tractus solitarii (DMK-cut) on plasma norepinephrine (NE), epinephrine (E), and vasopressin (VP) in conscious, tailartery-cannulated rats. In saline-pretreated (SAL) rats, DMK-cut caused a significant (p < 0.001) rise in mean blood pressu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1985
1985
1991
1991

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…In addition, we have shown that the rise in blood pressure which follows bilateral U50488H injections is associated with a marked increase in the level of circulating AVP. The possibility that the increase in blood pressure is mediated by a direct vasoconstrictor action of AVP is supported by recent studies showing that AVP functions as a rapidly acting and potent factor in both the recovery ofblood pressure following haemorrhage (Laycock, Penn, Shirley & Walter, 1979;Zerbe, Bayorh & Feuerstein, 1982; 372 OPIOIDS AND NUCLEUS TRACTUS SOLITARII Feuerstein, Bayorh, Zerbe & Kopin, 1984), and in the development of pressor responses (Hatzimkolaou, Gavras, Brunner & Gavras, 1981;Zukowska-Grojec, Bayorh, Zerbe, Palkovits & Kopin, 1983). Definitive evidence for a vasoconstrictor action ofAVP in the present study is lacking, but the results ofthe phenoxybenzamine experiments clearly indicate that sympathetic activation is not involved in the development of the U50488H-induced response.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, we have shown that the rise in blood pressure which follows bilateral U50488H injections is associated with a marked increase in the level of circulating AVP. The possibility that the increase in blood pressure is mediated by a direct vasoconstrictor action of AVP is supported by recent studies showing that AVP functions as a rapidly acting and potent factor in both the recovery ofblood pressure following haemorrhage (Laycock, Penn, Shirley & Walter, 1979;Zerbe, Bayorh & Feuerstein, 1982; 372 OPIOIDS AND NUCLEUS TRACTUS SOLITARII Feuerstein, Bayorh, Zerbe & Kopin, 1984), and in the development of pressor responses (Hatzimkolaou, Gavras, Brunner & Gavras, 1981;Zukowska-Grojec, Bayorh, Zerbe, Palkovits & Kopin, 1983). Definitive evidence for a vasoconstrictor action ofAVP in the present study is lacking, but the results ofthe phenoxybenzamine experiments clearly indicate that sympathetic activation is not involved in the development of the U50488H-induced response.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the K-agonist response appears to be specific since a 8-opioid agonist elicited similar effects in Brattleboro and Long-Evans rats, and the &-agonist pressor response was not significantly altered by the AVP antagonist, but was completely blocked by phenoxybenzamine. The possibility that the differential action of U50488H in Brattleboro and Long-Evans rats and the AVP antagonist blockade may be explained by central autonomic effects of AVP in the nucleus tractus solitarii (Matsuguchi, Sharali, Gordon, Johnson & Schmid, 1982;Pittman, Lawrence & McLean, 1982) cannot be ruled out, but such action appears unlikely in view of the observation that the cardiovascular response to centrally administered AVP is not dependent upon AVP release from the pituitary (Pittman et al 1982) and the demonstration that the dose of AVP antagonist which blocked the K-agonist pressor response by approximately 50 % has been shown previously (Kruszynski, Lammek, Manning, Seto, Haldar & Sawyer, 1980) Zerbe & Kopin, 1984), and in the development of pressor responses (Hatzimkolaou, Gavras, Brunner & Gavras, 1981;Zukowska-Grojec, Bayorh, Zerbe, Palkovits & Kopin, 1983). Definitive evidence for a vasoconstrictor action ofAVP in the present study is lacking, but the results ofthe phenoxybenzamine experiments clearly indicate that sympathetic activation is not involved in the development of the U50488H-induced response.…”
Section: Discussionmentioning
confidence: 99%